Displaying drugs 4876 - 4900 of 5886 in total
Rosa centifolia flower oil
Rosa centifolia flower oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental
Amotosalen
Investigational
3-Fluoro-2-Methyl-Aniline
Experimental
Alferminogene tadenovec
Alferminogene tadenovec, Cardium’s lead product candidate, is being developed for the potential treatment of myocardial ischemia that gives rise to angina symptoms associated with coronary heart disease. Alferminogene tadenovec represents a new therapeutic class of biologics designed to promote angiogenesis and thereby improve blood flow following a one-time intracoronary administration...
Investigational
o-Cymen-5-ol
Experimental
Fluorocyclopentenylcytosine
Fluorocyclopentenylcytosine is under investigation in clinical trial NCT03189914 (RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer).
Investigational
H3B-6527
H3B-6527 is under investigation in clinical trial NCT03424577 (A Study to Evaluate the Food-Effect of H3B-6527).
Investigational
WSD-0922
Investigational
PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE
Experimental
Aspartame
Flavoring agent sweeter than sugar, metabolized as phenylalanine and aspartic acid.
Investigational
Nutraceutical
Sophora flavescens root
Experimental
Ceftiofur
Ceftiofur is a third generation cephalosporin antibiotic, first described in 1987, and now used in veterinary medicine. It is marketed by pharmaceutical company Zoetis as Excenel, and is the active ingredient in that company's Specramast LC (lactating cow formula) product. It is resistant to hydrolysis by beta-lactamase, and has activity...
Vet approved
CAM-101
CAM-101 is an allogeneic human platelet lysate product depleted of fibrinogen.
Investigational
Farletuzumab ecteribulin
Farletuzumab ecteribulin is under investigation in clinical trial NCT04300556 (A Study to Evaluate the Safety, Tolerability, and Efficacy of Morab-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (Frα)-targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types).
Investigational
3,6-dihydroxy-xanthene-9-propionic acid
Experimental
D-leucyl-N-(3-chlorobenzyl)-L-prolinamide
Experimental
(2R)-1-(2,6-dimethylphenoxy)propan-2-amine
Experimental
L-tyrosinamide
Experimental
3-nitro-L-tyrosine
Experimental
Oseltamivir acid
Experimental
Malonyl-CoA
A coenzyme A derivative which plays a key role in the fatty acid synthesis in the cytoplasmic and microsomal systems.
Experimental
Reltecimod
Reltecimod is under investigation in clinical trial NCT02469857 (Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections).
Investigational
Pixofisiran
Investigational
Displaying drugs 4876 - 4900 of 5886 in total